Trials / Unknown
UnknownNCT04454034
Arthroscopic Synovectomy Combined With DMARDs in the Treatment of Refractory Elbow Rheumatoid Arthritis
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 25 (estimated)
- Sponsor
- Peking University Third Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- —
Summary
Rheumatoid arthritis (RA) is an autoimmune disease characterized by chronic and aggressive polyarthritis. The prevalence of RA in China is about 0.42%. Arthroscopic synovectomy (AS) is an important method to save the function of joint in the treatment of refractory RA. The clinical trial is to study the value of AS combine with DMARDs in the early stage of refractory RA.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | arthroscopic synovectomy | arthroscopic synovectomy |
Timeline
- Start date
- 2019-08-01
- Primary completion
- 2021-07-31
- Completion
- 2021-12-31
- First posted
- 2020-07-01
- Last updated
- 2021-06-28
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04454034. Inclusion in this directory is not an endorsement.